Who Paid My Doc
Chasady Freeze
Clinical Nurse Specialist, Family Health Bowling Green, OH Nurse Practitioner
NPI 1669726584 CMS profile 10605307
1039 Haskins Rd, Unit A, Bowling Green, OH 43402
General payments
$405
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Chasady Freeze of Bowling Green, OH is reported in the CMS Open Payments database as having received $405 across 25 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 55th percentile of Clinical Nurse Specialist, Family Health profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
4 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $103 | 6 | |
| 2023 | General | $132 | 9 | |
| 2022 | General | $149 | 9 | |
| 2021 | General | $21 | 1 |
Beside peers
- Chasady Freeze
- Clinical Nurse Specialist, Family Health median
- Middle half of Clinical Nurse Specialist, Family Health
- National median
In program year 2025, general payments to Chasady Freeze were reported at $103. Among 164 Clinical Nurse Specialist, Family Health profiles paid that year, the median was $216 and the middle half received between $57 and $492.
Show as a table
| Year | Chasady Freeze | Clinical Nurse Specialist, Family Health median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | — | — | $163 |
| 2020 | $0 | — | — | $114 |
| 2021 | $21 | $151 | $46–$400 | $132 |
| 2022 | $149 | $153 | $37–$527 | $149 |
| 2023 | $132 | $139 | $50–$451 | $160 |
| 2024 | $0 | $150 | $46–$571 | $164 |
| 2025 | $103 | $216 | $57–$492 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 104 drugsPart D claims
4,401
Drug cost
$427,023
Branded share of claims
24.4%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Jardiance Empagliflozin | Brand | 47 | $50,176 | |
| Trulicity Dulaglutide | Brand | 31 | $49,759 | |
| Ozempic Semaglutide | Brand | 27 | $42,145 | |
| Farxiga Dapagliflozin Propanediol | Brand | 34 | $37,044 | |
| Mounjaro Tirzepatide | Brand | 27 | $36,881 | |
| Januvia Sitagliptin Phosphate | Brand | 31 | $30,613 | |
| Eliquis Apixaban | Brand | 18 | $29,384 | |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | Brand | 28 | $22,060 | |
| Levothyroxine Sodium | Generic | 233 | $13,875 | |
| Xarelto Rivaroxaban | Brand | 17 | $13,373 |
The 10 drugs with the highest cost, of 104 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 32 billing codesPaid by Medicare
$32,591
Medicare patients
120
Services billed
650
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 63% | |
| Arthritis | 43% | |
| Depression | 24% | |
| Diabetes | 23% | |
| Chronic kidney disease | 20% | |
| Ischemic heart disease | 16% | |
| COPD | 12% | |
| Cancer | 12% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Vaccine for influenza for injection into muscle 90662 | Office | 21 | 21 | $1,718 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
25 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Clinical Nurse Specialist, Family Health in Ohio
Fred Wagshul
Clinical Nurse Specialist, Family Health · Dayton, OH
Sheri Dodds
Clinical Nurse Specialist, Family Health · Lancaster, OH
Lisa Ritenour
Clinical Nurse Specialist, Family Health · Canton, OH
Vicki Delany
Clinical Nurse Specialist, Family Health · Dublin, OH
Annette Saveski
Clinical Nurse Specialist, Family Health · Mansfield, OH
Juanita Krisher
Clinical Nurse Specialist, Family Health · Dayton, OH
Related records
Clinical Nurse Specialist, Family Health in Ohio
Practitioners in the same specialty and state, ranked by reported value.
All Clinical Nurse Specialist, Family Health
Everyone recorded under this specialty, nationwide.
Doctors in Ohio
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.